On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Hematology Oncology Consultants

InstitutionResearch output, impact & collaborations

Hematology Oncology Consultants is a institution indexed in ScholarIQ from OpenAlex.

What is known about Hematology Oncology Consultants?

ScholarIQrecord summary

Hematology Oncology Consultants is a research organisation in Royal Oak, US. OpenAlex records 1,296 works and 71,685 citations for it. 376 researchers list it as their most recent affiliation.

How many works does Hematology Oncology Consultants have?

ScholarIQindexed works

Hematology Oncology Consultants has 1,296 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Hematology Oncology Consultants have?

ScholarIQcitation count

Hematology Oncology Consultants has 71,685 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Hematology Oncology Consultants?

ScholarIQresearcher count

Hematology Oncology Consultants has 376 researchers in the ScholarIQ index.

What is the average h-index at Hematology Oncology Consultants?

ScholarIQavg h-index

Hematology Oncology Consultants has an average h-index of 65 in OpenAlex.

What is the ROR of Hematology Oncology Consultants?

ScholarIQror

The ROR for Hematology Oncology Consultants is on the source record.

What is the OpenAlex record for Hematology Oncology Consultants?

ScholarIQopenalex

The OpenAlex for Hematology Oncology Consultants is on the source record.

Who are the most-cited researchers behind Hematology Oncology Consultants?

ScholarIQtop researchers by citations
1
David Rodbard · Diabetes Management and Research
290 works35,895 citations
2
James E. Krook · Cancer Treatment and Pharmacology
152 works19,035 citations

What are the most-cited papers on Hematology Oncology Consultants?

ScholarIQmost cited works
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
David C. Klonoff, Jing Wang, David Rodbard, Michael A. Kohn, Chengdong Li, Dorian Liepmann, David Kerr, David Ahn, Anne L. Peters, Guillermo E. Umpierrez, Jane Jeffrie Seley, Nicole Y. Xu, Kevin T. Nguyen, Gregg D. Simonson, Michael S. D. Agus, Mohammed E. Al‐Sofiani, Gustavo Armaiz-Peña, Timothy S. Bailey, Ananda Basu, Tadej Battelino, Sewagegn Yeshiwas, Pierre‐Yves Benhamou, B. Wayne Bequette, Thomas Blevins, Marc D. Breton, Jessica R. Castle, J. Geoffrey Chase, Kong Y. Chen, Pratik Choudhary, Mark A. Clements, Kelly L. Close, Curtiss B. Cook, Thomas Danne, Francis J. Doyle, Angela Drincic, Kathleen Dungan, Steven V. Edelman, Niels Ejskjær, Juan Espinoza, G. Alexander Fleming, Gregory P. Forlenza, Guido Freckmann, Rodolfo J. Galindo, Ana María Gómez, Hanna A. Gutow, Lutz Heinemann, Irl B. Hirsch, Thanh D. Hoang, Roman Hovorka, Johan Jendle, Linong Ji, Shashank Joshi, Michaël Joubert, Suneil K. Koliwad, Rayhan Lal, M. Cecilia Lansang, Wei-An Lee, Lalantha Leelarathna, Lawrence A. Leiter, Marcus Lind, Michelle L. Litchman, Julia K. Mader, Katherine Mahoney, Boris Mankovsky, Umesh Masharani, Nestoras Mathioudakis, Alexander Yur'evich Mayorov, Jordan Messler, Joshua D. Miller, Viswanathan Mohan, James H. Nichols, Kirsten Nørgaard, David N. O’Neal, Francisco J. Pasquel, Athena Philis‐Tsimikas, Thomas R. Pieber, Moshe Phillip, William H. Polonsky, Rodica Pop‐Busui, Gerry Rayman, Eun‐Jung Rhee, Steven J. Russell, Viral N. Shah, Jennifer L. Sherr, Koji Sode, Elias K. Spanakis, Deborah J. Wake, Kayo Waki, Amisha Wallia, Melissa E. Weinberg, Howard Wolpert, Eugene E. Wright, Mihail Zilbermint, Boris Kovatchev
Journal of Diabetes Science and Technology. 2022286 CitationsOPEN ACCESS
Phase III, Randomized, Double-Blind Study of Epoetin Alfa Compared With Placebo in Anemic Patients Receiving Chemotherapy
Thomas E. Witzig, Peter T. Silberstein, Charles L. Loprinzi, Jeff A. Sloan, Paul J. Novotny, James A. Mailliard, Kendrith M. Rowland, Steven R. Alberts, James E. Krook, Ralph Levitt, Roscoe F. Morton
Journal of Clinical Oncology. 2004209 CitationsOPEN ACCESS

How much of the research on Hematology Oncology Consultants is open access?

ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
100%
Closed
0%

Related on ScholarIQ

470M+ articles · 14-day free trial